Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: Neuroendocrine properties of tumors associated with Carney complex

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1122-1128

  Stratakis, Constantine A ^a   Carney, J Aidan ^b   Kirschner, Lawrence S ^a   Willenberg, Holger S ^c   Brauer, Silke ^d   Ehrhart Bornstein, Monika ^d   Bornstein, Stefan R ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b MAYO CLINIC   (United States)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CHROMOGRANIN A; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ADRENAL CORTEX CELL; ADULT; ARTICLE; CARNEY COMPLEX; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; CUSHING SYNDROME; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MYXOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; TUMOR DIFFERENTIATION;

EID: 0033027686     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.3.5549     Document Type: Article

References (35)

1. Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. 1997 Morphological and functional studies of the paracrine interaction between cortex and medulla in the adrenal gland. Microsc Res Tech. 36:520-533.
2. Haak HR, Fleuren GJ. 1995 Neuroendocrine differentiation of adrenocortical tumors. Cancer. 75:860-864.
3. Komminoth P, Roth J, Schroder S, Saremaslani P, Heitz PU. 1995 Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest. 72:424-431.
4. Ehrhart-Bornstein M, Hilbers U. 1998 Neuroendocrine properties of adrenocortical cells. Horm Metab Res. 30:436-439.
5. Kapas S, Martinez A, Cuttita F, Hinson JP. 1998 Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J Endocrinol. 156:477-484.
6. Hinson JP, Kapas S. Regulation of vasoactive intestinal peptide in the rat adrenal gland [Abstract]. Proc of the 10th Int Congr of Endocrinol. 1996; P1-361.
7. Skogseid B, Larsson C, Lindgren PG, et al. 1992 Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 75:76-81.
8. Miettinen M. 1992 Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy. Lab Invest. 66:169-174.
9. Carney JA, Young WF. 1992 Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist. 2:6-21.
10. Stratakis CA, Carney JA, Lin J-P, et al. 1996 Carney complex, a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 97:699-705.
11. Casey M, Mah C, Merliss AD, et al. 1998 Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation. 98:2560-2566.
12. Chandrasekharappa SC, Guru SC, Manickam P, et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 276:404-407.
13. Liaw D, Marsh DJ, Li J, et al. 1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 16:64-67.
14. Hemminki A, Markie D, Tomlison I, et al. 1998 A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:184-187.
15. Jenne DE, Reimann H, Nezu J, et al. 1998 Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 18:38-43.
16. Shenoy BV, Carpenter PC, Carney JA. 1984 Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol. 8:335-344.
17. Carney JA, GordonH, Carpenter PC, Shenoy BV, Go VLW. 1985 The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine. 64:270-283.
18. Sasano H, Miyazaki S, Sawai T, et al. 1992 Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod Pathol. 5:23-29.
19. Carney JA. 1985 Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol. 9:53-55.
20. Reynen K. 1995 Cardiac myxomas. N Engl J Med. 333:1610-1617.
21. Dewald GW, Dahl RJ, Spurbeck JL, Carney JA, Gordon H. 1987 Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin Proc. 62:558-567.
22. Stratakis CA, Jenkins RB, Pras E, et al. 1996 Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overacrivity (Carney complex). J Clin Endocrinol Metab. 81:3607-3614.
23. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA. 1994 Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab. 78:225-232.
24. Bornstein SR, Ehrhart-Bornstein M, Usadel H, Bockmann M, Scherbaum WA. 1991 Morphological evidence for a close interaction of chromaffin cells with cortical cells within the adrenal gland. Cell Tissue Res. 265:1-9.
25. Erlandson RA, Nesland JM. 1994 Tumors of the endocrine/neuroendocrine system: an overview. Ultrastruct Pathol. 18:149-170.
26. Wiedenmmann B, Franke WW. 1985 Identification and localization of synaptophysin an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell. 41:1017-1028.
27. Miettinen M. 1987 Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Arch Pathol Lab Med. 111:813-818.
28. Chejfec G, Falkmer S, Grimelius L, et al. 1987 Synaptophysin. A new marker for pancreatic neuroendocrine tumors. Am J Surg Pathol. 11:241-247.
29. Buffa R, Rindi G, Sessa F, et al. 1988 Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours. Mol Cell Probes. 2:367-381.
30. Li Q, Johansson H, Kjellman M, Grimelius L. 1998 Neuroendocrine differentiation and nerves in human adrenal cortex and cortical lesions. APMIS. 106:807-817.
31. Lacroix A, Bolte E, Tremblay J, et al. 1992 Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. N Engl J Med. 327:974-980.
32. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. 1992 Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 327:981-986.
33. Lacroix A, Tremblay J, Touyz RM, et al. 1997 Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab. 82:2414-2422.
34. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. 1997 Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med. 337:1429-1434.
35. Willenbberg H, Stratakis CA, Ehrhart-Bornstein M, Marx C, Chrousos GP, Bornstein SR. 1998 Cytokine-induced ACTH-independent Cushing syndrome. N Engl J Med. 339:27-31.